About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00034892·26 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

With

University of North Carolina

Age

16–40

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients must meet criteria for schizophreniform disorder, schizophrenia, or schizoaffective disorder with psychotic symptoms lasting 1-60 months
Psychotic symptoms must have persisted at least one month, and not more thn 5 years (60 months)
Patients must have no previous history of drug treatment (greater than a total of 16 weeks) with antipsychotics

You may not be if

Patients with history of psychotic disorder with recovery period of at least 3 months
Female patients who are pregnant or nursing
Patients with a known history of mental retardation

The record

StatusCompleted

PhasePhase 3

Taking part—

StartedMar 2002

UpdatedJan 4, 2013

Conditions

Schizophrenia Psychotic Disorders Mental Health Mental Disorders

Where26

Stanford, California, United States
Miami, Florida, United States
Atlanta, Georgia, United States

Clareo Health | CAFE Comparison of Atypicals in First Episode of Psychosis